{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:31:55Z","timestamp":1787045515911,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Preventive Medicine Association","award":["2025-47"],"award-info":[{"award-number":["2025-47"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mpox has been twice declared as public health emergency of international concern by World Health Organization. The 2022\u20132024 global outbreak has been primarily driven by sexual transmission within men who have sex with men (MSM) networks, predominantly involving Clade IIb, with a subsequent surge of Clade Ib in early 2024. MSM account for a large proportion of confirmed mpox cases. This review aimed to estimate the prevalence of mpox infection among MSM populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched PubMed, Web of Science, Embase, China National Knowledge Infrastructure (CNKI) and Wanfang Data for studies published in English or Chinese from inception to 16 December 2024. Eligible studies reported mpox cases among MSM with confirmed diagnosis (laboratory or self-reported) during the outbreak period. Reviews, case reports, and studies without case numbers were excluded. American Agency for Healthcare Research and Quality and Newcastle-Ottawa Scale were adopted for quality assessment. Fixed-effects or random-effects meta-analysis was performed to estimate the pooled prevalence of mpox among MSM. Heterogeneity was measured using Cochran's Q test and\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      statistics. Meta regression analysis was performed to discover the potential source of the heterogeneity. Funnel plot, Egger's regression test and Begg's rank correlation test were conducted to evaluate the publication bias. Sensitivity analyses were performed by leave-one-out analysis and by stratified validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 1606 retrieved studies, 28 studies were eligible and included, containing a total of 46,598 MSM participants and 1274 mpox cases from 15 countries. The pooled mpox prevalence among MSM population was 2.30% [95% confidence interval (\n                      <jats:italic>CI<\/jats:italic>\n                      ): 1.29\u20133.57%]. Meta-regression identified continent as the most significant moderator, with prevalence in South America (9.58, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 2.71\u201320.01%) being significantly higher than in Asia (1.14, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.56\u20131.90%) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019). Sampling method also contributed to the heterogeneity, whereas no statistically significant difference was observed in mpox prevalence among high-risk MSM, asymptomatic MSM, comparing to the general MSM populations respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study confirms a significant but highly heterogeneous burden of mpox among MSM worldwide. The findings suggest that the observed prevalence is shaped more by regional epidemiological contexts and study methodologies, which emphasizes the necessity for geographically prioritized interventions and standardizing surveillance to enable accurate risk assessment and guide resource allocation in future outbreaks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40249-026-01493-y","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:42:20Z","timestamp":1787038940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of mpox infection among men who have sex with men: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Luqiu","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"1493_CR1","unstructured":"Breman JG, Kalisa-Ruti, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970\u201379. Bull World Health Organ. 1980;58(2):165\u2013182."},{"key":"1493_CR2","unstructured":"Multi-country outbreak of mpox, External situation report no. 62. https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report--62---23-january-2026. Accessed 03 Feb 2026."},{"key":"1493_CR3","doi-asserted-by":"crossref","unstructured":"Srivastava S, Laxmi, Sharma K, Sridhar SB, Talath S, Shareef J, et al. Clade Ib: a new emerging threat in the mpox outbreak. Front Pharmacol. 2024;15:1504154.","DOI":"10.3389\/fphar.2024.1504154"},{"key":"1493_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2024.102753","volume":"61","author":"R Sah","year":"2024","unstructured":"Sah R, Apostolopoulos V, Mehta R, Rohilla R, Sah S, Mohanty A, et al. Mpox strikes once more in 2024: declared again as a public health emergency of international concern. Travel Med Infect Dis. 2024;61:102753.","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"1493_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/v17060753","volume":"17","author":"R Yadav","year":"2022","unstructured":"Yadav R, Chaudhary AA, Srivastava U, Gupta S, Rustagi S, Rudayni HA, et al. Mpox 2022 to 2025 update: a comprehensive review on its complications, transmission, diagnosis, and treatment. Viruses. 2022;17(6):753.","journal-title":"Viruses"},{"issue":"1","key":"1493_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.24-0606","volume":"112","author":"A Zumla","year":"2024","unstructured":"Zumla A, Rosenthal PJ, Sam-Agudu NA, Ogoina D, Mbala-Kingebeni P, Ntoumi F, et al. The 2024 public health emergency of international concern: a global failure to control mpox. Am J Trop Med Hyg. 2024;112(1):17\u201320.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"1493_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122083","volume":"10","author":"P Satapathy","year":"2022","unstructured":"Satapathy P, Mohanty P, Manna S, Shamim MA, Rao PP, Aggarwal AK, et al. Potentially asymptomatic infection of monkeypox virus: a systematic review and meta-analysis. Vaccines. 2022;10(12):2083.","journal-title":"Vaccines"},{"issue":"3","key":"1493_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","volume":"17","author":"PE Fine","year":"1988","unstructured":"Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988;17(3):643\u201350.","journal-title":"Int J Epidemiol"},{"issue":"10370","key":"1493_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. Lancet. 2023;401(10370):60\u201374.","journal-title":"Lancet"},{"key":"1493_CR10","doi-asserted-by":"publisher","first-page":"8845911","DOI":"10.1155\/ghe3\/8845911","volume":"2025","author":"A Akingbola","year":"2025","unstructured":"Akingbola A, Abiodun A, Idahor C, Peters F, Ojo O, Jessica OU, et al. Genomic evolution and epidemiological impact of ongoing clade Ib MPox disease: a narrative review. Glob Health Epidemiol Genom. 2025;2025:8845911.","journal-title":"Glob Health Epidemiol Genom"},{"issue":"8","key":"1493_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries\u2014April-June 2022. N Engl J Med. 2022;387(8):679\u201391.","journal-title":"N Engl J Med"},{"issue":"10353","key":"1493_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","volume":"400","author":"EJ Tar\u00edn-Vicente","year":"2022","unstructured":"Tar\u00edn-Vicente EJ, Alemany A, Agud-Dios M, Ubals M, Su\u00f1er C, Ant\u00f3n A, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022;400(10353):661\u20139.","journal-title":"Lancet"},{"issue":"7","key":"1493_CR13","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1016\/S2214-109X(23)00198-5","volume":"11","author":"H Laurenson-Schafer","year":"2023","unstructured":"Laurenson-Schafer H, Sklenovsk\u00e1 N, Hoxha A, Kerr SM, Ndumbi P, Fitzner J, et al. Description of the first global outbreak of mpox: an analysis of global surveillance data. Lancet Glob Health. 2023;11(7):e1012\u201323.","journal-title":"Lancet Glob Health"},{"issue":"44","key":"1493_CR14","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.15585\/mmwr.mm7144e1","volume":"71","author":"MJ Miller","year":"2022","unstructured":"Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, et al. Severe monkeypox in hospitalized patients\u2014United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(44):1412\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10380","key":"1493_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Alemany A, Marks M, Lezama Mora JI, Rodr\u00edguez-Aldama JC, Torres Silva MS, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023;401(10380):939\u201349.","journal-title":"Lancet"},{"issue":"33\u201334","key":"1493_CR16","first-page":"551","volume":"119","author":"C Hoffmann","year":"2022","unstructured":"Hoffmann C, Jessen H, Boesecke C. Monkeypox in Germany. Dtsch Arztebl Int. 2022;119(33\u201334):551\u20137.","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"1493_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29621","volume":"96","author":"GS Lira","year":"2024","unstructured":"Lira GS, Ota VA, Melo MQS, Casti\u00f1eiras ACP, Leit\u00e3o IC, Silva BO, et al. Mpox outbreak in Rio de Janeiro, Brazil: a translational approach. J Med Virol. 2024;96(5):e29621.","journal-title":"J Med Virol"},{"issue":"2","key":"1493_CR18","doi-asserted-by":"publisher","first-page":"2254407","DOI":"10.1080\/22221751.2023.2254407","volume":"12","author":"X Dou","year":"2023","unstructured":"Dou X, Li F, Ren Z, Zhang D, Li J, Li D, et al. Clinical, epidemiological, and virological features of Mpox in Beijing, China\u2014May 31-June 21, 2023. Emerg Microbes Infect. 2023;12(2):2254407.","journal-title":"Emerg Microbes Infect"},{"issue":"11","key":"1493_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22129","volume":"9","author":"N Sharif","year":"2023","unstructured":"Sharif N, Dey SK. Epidemiology of mpox: focus on men with HIV. Heliyon. 2023;9(11):e22129.","journal-title":"Heliyon"},{"issue":"2","key":"1493_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cmi.2022.08.012","volume":"29","author":"M Mailhe","year":"2023","unstructured":"Mailhe M, Beaumont AL, Thy M, Le Pluart D, Perrineau S, Houhou-Fidouh N, et al. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study. Clin Microbiol Infect. 2023;29(2):233\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"6615","key":"1493_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.add4507","volume":"378","author":"A Endo","year":"2022","unstructured":"Endo A, Murayama H, Abbott S, Ratnayake R, Pearson CAB, Edmunds WJ, et al. Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022. Science. 2022;378(6615):90\u20134.","journal-title":"Science"},{"issue":"8","key":"1493_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102799","volume":"18","author":"F Ned\u00e9nyi","year":"2025","unstructured":"Ned\u00e9nyi F, Benke JM, Szalai M, R\u00f6st G. Risk of evolution driven population-wide emergence of mpox: the paradoxic effect of moderate interventions. J Infect Public Health. 2025;18(8):102799.","journal-title":"J Infect Public Health"},{"issue":"7","key":"1493_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"1493_CR24","first-page":"1","volume":"104","author":"A Rostom","year":"2004","unstructured":"Rostom A, Dub\u00e9 C, Cranney A, Saloojee N, Sy R, Garritty C, et al. Celiac disease. Evid Rep Technol Assess (Summ). 2004;104:1\u20136.","journal-title":"Evid Rep Technol Assess (Summ)"},{"issue":"4","key":"1493_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/jebm.12445","volume":"14","author":"SA Doi","year":"2021","unstructured":"Doi SA, Xu C. The Freeman-Tukey double arcsine transformation for the meta-analysis of proportions: recent criticisms were seriously misleading. J Evid Based Med. 2021;14(4):259\u201361.","journal-title":"J Evid Based Med"},{"issue":"2","key":"1493_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97\u2013111.","journal-title":"Res Synth Methods"},{"key":"1493_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073141","volume":"381","author":"MH Murad","year":"2023","unstructured":"Murad MH, Wang Z, Zhu Y, Saadi S, Chu H, Lin L. Methods for deriving risk difference (absolute risk reduction) from a meta-analysis. BMJ. 2023;381:e073141.","journal-title":"BMJ"},{"issue":"7414","key":"1493_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"13","key":"1493_CR29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jama.2024.17829","volume":"332","author":"C Rivers","year":"2024","unstructured":"Rivers C, Watson C, Phelan AL. The resurgence of mpox in Africa. JAMA. 2024;332(13):1045\u20136.","journal-title":"JAMA"},{"issue":"20","key":"1493_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.15585\/mmwr.mm7220a2","volume":"72","author":"JH McQuiston","year":"2022","unstructured":"McQuiston JH, Braden CR, Bowen MD, McCollum AM, McDonald R, Carnes N, et al. The CDC domestic mpox response\u2014United States, 2022-2023. MMWR Morb Mortal Wkly Rep. 2022;72(20):547\u201352.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1493_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-017268","volume":"10","author":"R McCabe","year":"2025","unstructured":"McCabe R, Johnson LF, Whittles LK. Estimating the burden of mpox among MSM in South Africa. BMJ Glob Health. 2025;10(2):e017268.","journal-title":"BMJ Glob Health"},{"key":"1493_CR32","unstructured":"Global mpox trends. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/. Accessed 27 Jun 2025."},{"key":"1493_CR33","unstructured":"Regional Report\u2014Central America, North America and the Caribbean (January\u2013June 2023). https:\/\/reliefweb.int\/report\/venezuela-bolivarian-republic\/regional-report-central-america-north-america-and-caribbean-january-june-2023. Accessed 03 Feb 2026."},{"issue":"1","key":"1493_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/QAD.0000000000003748","volume":"38","author":"MST Silva","year":"2024","unstructured":"Silva MST, Coutinho C, Torres TS, Peixoto EM, Bastos MO, Mesquita MB, et al. Mpox severity and associated hospitalizations among people with HIV and related immunosuppression in Brazil. AIDS. 2024;38(1):105\u201313.","journal-title":"AIDS"},{"issue":"3","key":"1493_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/phn.13308","volume":"41","author":"GRS Santos","year":"2024","unstructured":"Santos GRS, Ribeiro CJN, Lima SVMA, Neto JC, de Sousa AR, Bulcao CDS, et al. Chemsex among men who have sex with men during the Mpox health crisis in Brazil: a nationwide web survey. Public Health Nurs. 2024;41(3):589\u2013601.","journal-title":"Public Health Nurs"},{"key":"1493_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101020","volume":"45","author":"J Ghosn","year":"2024","unstructured":"Ghosn J, Assoumou L, Ouattara M, Rubenstein E, Pialoux G, Katlama C, et al. Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial. Lancet Reg Health Eur. 2024;45:101020.","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"1493_CR37","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2666-5247(22)00291-9","volume":"4","author":"B Hernaez","year":"2023","unstructured":"Hernaez B, Mu\u00f1oz-G\u00f3mez A, Sanchiz A, Orviz E, Valls-Carbo A, Sagastagoitia I, et al. Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study. Lancet Microbe. 2023;4(1):e21\u20138.","journal-title":"Lancet Microbe"},{"issue":"5","key":"1493_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jinf.2022.07.022","volume":"85","author":"AR Raccagni","year":"2022","unstructured":"Raccagni AR, Candela C, Mileto D, Canetti D, Bruzzesi E, Rizzo A, et al. Monkeypox infection among men who have sex with men: PCR testing on seminal fluids. J Infect. 2022;85(5):573\u2013607.","journal-title":"J Infect"},{"issue":"2","key":"1493_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(22)00651-X","volume":"23","author":"KM Angelo","year":"2023","unstructured":"Angelo KM, Smith T, Camprub\u00ed-Ferrer D, Balerdi-Sarasola L, D\u00edaz Men\u00e9ndez M, Servera-Negre G, et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2023;23(2):196\u2013206.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1493_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28713","volume":"95","author":"H Shin","year":"2023","unstructured":"Shin H, Shin H, Rahmati M, Koyanagi A, Jacob L, Smith L, et al. Comparison of clinical manifestations in mpox patients living with HIV versus without HIV: a systematic review and meta-analysis. J Med Virol. 2023;95(4):e28713.","journal-title":"J Med Virol"},{"issue":"3","key":"1493_CR41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3201\/eid2903.221845","volume":"29","author":"RM Burdon","year":"2023","unstructured":"Burdon RM, Atefi D, Rana J, Parasuraman A, Lee AS, Nield B. Sustained Mpox proctitis with primary syphilis and HIV seroconversion, Australia. Emerg Infect Dis. 2023;29(3):647\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"1493_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4103\/jfmpc.jfmpc_275_18","volume":"7","author":"SA Raza","year":"2018","unstructured":"Raza SA, Salemi JL, Zoorob RJ. Historical perspectives on prevention paradox: when the population moves as a whole. J Fam Med Prim Care. 2018;7(6):1163\u20135.","journal-title":"J Fam Med Prim Care"},{"issue":"4","key":"1493_CR43","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/S2666-5247(22)00379-2","volume":"4","author":"S Accordini","year":"2023","unstructured":"Accordini S, Cordioli M, Pomari E, Tacconelli E, Castilletti C. People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission. Lancet Microbe. 2023;4(4):e209.","journal-title":"Lancet Microbe"},{"issue":"10","key":"1493_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0335729","volume":"20","author":"I Armenteros-Yeguas","year":"2025","unstructured":"Armenteros-Yeguas I, Homen R, Valls A, Dans L, Orviz E, Ayerdi O, et al. Screening for asymptomatic mpox in at-risk populations: a cross-sectional study. PLoS ONE. 2025;20(10):e0335729.","journal-title":"PLoS ONE"},{"issue":"11","key":"1493_CR45","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1016\/S2666-5247(23)00248-3","volume":"4","author":"B Hampel","year":"2023","unstructured":"Hampel B, Farnham A, Lamothe-Molina PJ, Capelli C, Schibler M, Ustero Alonso P, et al. Low prevalence of asymptomatic mpox in populations at high risk. Lancet Microbe. 2023;4(11):e856.","journal-title":"Lancet Microbe"},{"issue":"6","key":"1493_CR46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/pathogens12060798","volume":"12","author":"R Rossotti","year":"2023","unstructured":"Rossotti R, Calzavara D, Cernuschi M, D\u2019Amico F, De Bona A, Repossi R, et al. Detection of asymptomatic mpox carriers among high-Ri men who have sex with men: a prospective analysis. Pathogens. 2023;12(6):798.","journal-title":"Pathogens"},{"key":"1493_CR47","doi-asserted-by":"crossref","unstructured":"Van Dijck C, De Baetselier I, Kenyon C, Liesenborghs L; ITM Monkeypox Study Group; Vercauteren K, et al. Mpox screening in high-risk populations finds no asymptomatic cases. Lancet Microbe. 2023;4(3):e132\u2013e133.","DOI":"10.1016\/S2666-5247(22)00357-3"},{"key":"1493_CR48","doi-asserted-by":"crossref","unstructured":"Yan Y, Sun Y, Sun G, Niu C, Zhao X, Zhao M, et al. Monkeypox virus: Epidemiology, virology, diagnosis, vaccine, and therapeutics. MedComm (2020). 2026;7(1):e70525.","DOI":"10.1002\/mco2.70525"},{"key":"1493_CR49","doi-asserted-by":"publisher","first-page":"04070","DOI":"10.7189\/jogh.15.04070","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang M, Wang Y, Li C, Xu H, Xu G, et al. Psychosocial correlates of free Mpox vaccination intention among men who have sex with men in China: model construction and validation. J Glob Health. 2025;15:04070.","journal-title":"J Glob Health"},{"issue":"2","key":"1493_CR50","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v4i2.866","volume":"4","author":"D Indiastari","year":"2024","unstructured":"Indiastari D, Fajar JK, Tamara F, Runesi O, Hakim LN, Chotimah K, et al. Global prevalence and determinants associated with the acceptance of monkeypox vaccination. Narra J. 2024;4(2):e866.","journal-title":"Narra J"},{"issue":"1","key":"1493_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s43856-024-00564-1","volume":"4","author":"SK Sulaiman","year":"2024","unstructured":"Sulaiman SK, Isma\u2019il Tsiga-Ahmed F, Musa MS, Makama BT, Sulaiman AK, Abdulaziz TB. Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis. Commun Med (Lond). 2024;4(1):136.","journal-title":"Commun Med (Lond)"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-026-01493-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-026-01493-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-026-01493-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:02:47Z","timestamp":1787043767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40249-026-01493-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/s40249-026-01493-y","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wei Wang is an editorial board member of the journal\n                      Infectious Diseases of Poverty\n                      . He was not involved in the peer-review or handling of the manuscript. The authors have no other competing interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"89"}}